Immunogenicity and protective efficacy of an EB66® cell culture-derived duck Tembusu virus vaccine. Issue 5 (2nd September 2020)
- Record Type:
- Journal Article
- Title:
- Immunogenicity and protective efficacy of an EB66® cell culture-derived duck Tembusu virus vaccine. Issue 5 (2nd September 2020)
- Main Title:
- Immunogenicity and protective efficacy of an EB66® cell culture-derived duck Tembusu virus vaccine
- Authors:
- Yang, Zhiyuan
Wang, Jiaqi
Wang, Xiuqing
Duan, Huijuan
He, Pingyou
Yang, Guijun
Liu, Lixin
Cheng, Huimin
Wang, Xiaolei
Pan, Jie
Zhao, Jicheng
Yu, Hongwei
Yang, Baoshou
Liu, Yuehuan
Lin, Jian - Abstract:
- ABSTRACT: The avian EB66 ® cell line, derived from duck embryonic stem cells, has been widely used for producing human and animal therapeutic proteins and vaccines. In current study we evaluated the potential use of EB66 ® cell line in a cell culture-derived duck Tembusu virus (DTMUV) vaccine development. After optimizing the growth conditions of DTMUV HB strain in EB66 ® cells, we successfully generated three batches of viruses with ELD50 titres of 10 5.9 /0.1 ml, 10 5.3 /0.1 ml and 10 5.5 /0.1 ml, respectively, for using in the preparation of inactivated vaccines. The immunogenicity and protective efficacy of these EB66 ® cells-derived inactivated vaccines were examined in ducks. Results indicated that all three batches of vaccines induced haemagglutination-inhibition (HI) antibody response in immunized birds at 2 weeks after a single immunization. Immunized ducks and ducklings were protected against a virulent challenge at 4 weeks after a booster immunization. The duration of immunity was for 3–4 months after a booster immunization. These results demonstrated the feasibility of using EB66 ® cell line to grow up DTMUV for vaccine preparation. RESEARCH HIGHLIGHTS Duck Tembusu virus can be propagated in EB66 ® cells. EB66 ® cell-derived inactivated DTMUV vaccines are immunogenic and can provide protection against a virulent challenge. A long-lasting immunity is induced after a booster immunization.
- Is Part Of:
- Avian pathology. Volume 49:Issue 5(2020)
- Journal:
- Avian pathology
- Issue:
- Volume 49:Issue 5(2020)
- Issue Display:
- Volume 49, Issue 5 (2020)
- Year:
- 2020
- Volume:
- 49
- Issue:
- 5
- Issue Sort Value:
- 2020-0049-0005-0000
- Page Start:
- 448
- Page End:
- 456
- Publication Date:
- 2020-09-02
- Subjects:
- Duck -- Tembusu virus -- EB66® cell line -- inactivated vaccine -- immunogenicity -- efficacy
Poultry -- Diseases -- Periodicals
Birds -- Diseases -- Periodicals
571.918 - Journal URLs:
- http://www.tandfonline.com/toc/cavp20/current ↗
http://www.tandfonline.com/ ↗ - DOI:
- 10.1080/03079457.2020.1763914 ↗
- Languages:
- English
- ISSNs:
- 0307-9457
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 1837.891000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 22354.xml